SCHEMBL21998536

SCHEMBL21998536

c1ccc(C(=C(c2ccccc2)c2ccc(-c3ccc(N(c4ccccc4)c4ccc(-c5ccc(C(=C(c6ccccc6)c6ccccc6)c6ccccc6)cc5)cc4)cc3)cc2)c2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.46
ALDH1A1 P00352 5/20 0.46
L3MBTL1 Q9Y468 5/20 0.46
CYP1A2 P05177 2/20 0.46
KDM4E B2RXH2 2/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
RAB9A P51151 5/20 0.41
MEN1 O00255 4/20 0.41
KMT2A Q03164 4/20 0.41
NPC1 O15118 2/20 0.41
LMNA P02545 2/20 0.41
CTDSP1 Q9GZU7 1/20 0.41
HPGD P15428 4/20 0.40
SMN1; SMN2 Q16637 4/20 0.39
CRHBP P24387 1/20 0.39
ATM Q13315 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12330849 1.00 MAPT (0.46) MAPTALDH1A1L3MBTL1CYP1A2KDM4E
SCHEMBL14132570 1.00 MAPT (0.46) MAPTALDH1A1L3MBTL1CYP1A2KDM4E
SCHEMBL21998530 1.00 MAPT (0.46) MAPTALDH1A1L3MBTL1CYP1A2KDM4E
SCHEMBL13515151 1.00 MAPT (0.46) MAPTALDH1A1L3MBTL1CYP1A2KDM4E
SCHEMBL13515173 1.00 MAPT (0.46) MAPTALDH1A1L3MBTL1CYP1A2KDM4E
SCHEMBL23471561 0.98 MAPT (0.45) MAPTALDH1A1L3MBTL1CYP1A2KDM4E
SCHEMBL13808676 0.98 MAPT (0.43) MAPTALDH1A1L3MBTL1CYP1A2KDM4E
SCHEMBL15858556 0.96 ALDH1A1 (0.46) MAPTALDH1A1L3MBTL1CYP1A2KDM4E
SCHEMBL15858549 0.96 ALDH1A1 (0.46) MAPTALDH1A1L3MBTL1CYP1A2KDM4E
SCHEMBL13515162 0.93 ALDH1A1 (0.52) MAPTALDH1A1L3MBTL1CYP1A2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220048923-A1 LUMINOGENS FOR BIOLOGICAL APPLICATIONS THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2022-02-17 US disclosed
US-11186586-B2 Luminogens for biological applications THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2021-11-30 US disclosed
US-20200147078-A1 THERANOSTIC AGENTS THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) 2020-05-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220048923-A1 LUMINOGENS FOR BIOLOGICAL APPLICATIONS BTD, TPD52L2, TTPA MAPT 416/4885ALDH1A1 1770/4885L3MBTL1 66/4885
US-11186586-B2 Luminogens for biological applications BTD, LTA, TPD52L2 MAPT 576/4885ALDH1A1 2344/4885L3MBTL1 68/4885
US-20200147078-A1 THERANOSTIC AGENTS FAP, MKI67, PAIP1 MAPT 2200/4885ALDH1A1 1066/4885L3MBTL1 1108/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.